← back to search

Ana Antonic‐Baker

Alfred Health ·
Area of research
Psychiatry and Mental health · Molecular Biology
Research interest
Research interests include Epilepsy research and treatment, Pluripotent Stem Cells Research, Pharmacological Effects and Toxicity Studies, and Traumatic Brain Injury Research.
h-index
19
citations
1,576
works
53
NIH funding
primary concept
email

Recent publications

Electrical stimulation of stem cell–derived human neural networks for evaluating anti‐seizure medications
Epilepsia 2025cited by 2position: middledoi
The Australian Traumatic Brain Injury Initiative: Systematic Review and Consensus Process to Determine the Predictive Value of Pre-existing Health Conditions for People with Moderate-Severe Traumatic Brain Injury
Journal of Neurotrauma 2024cited by 7position: firstdoi
The Australian Traumatic Brain Injury Initiative: Systematic Review of the Effect of Acute Interventions on Outcome for People With Moderate-Severe Traumatic Brain Injury
Journal of Neurotrauma 2024cited by 5position: middledoi
The Australian Traumatic Brain Injury Initiative: Systematic Review of Clinical Factors Associated with Outcomes in People with Moderate-Severe Traumatic Brain Injury
Neurotrauma Reports 2024cited by 0position: middledoi
The Australian Traumatic Brain Injury Initiative: Systematic Review and Consensus Process to Determine the Predictive Value of Demographic, Injury Event, and Social Characteristics on Outcomes for People With Moderate-Severe Traumatic Brain Injury
Journal of Neurotrauma 2023cited by 8position: middledoi
The Australian Traumatic Brain Injury Initiative: Systematic Review of Predictive Value of Biological Markers for People With Moderate-Severe Traumatic Brain Injury
Journal of Neurotrauma 2023cited by 6position: middledoi
Outcome heterogeneity and bias in acute experimental spinal cord injury
Neurology 2019cited by 40position: middledoi
Differential susceptibility of human neural progenitors and neurons to ischaemic injury
Brain Research Bulletin 2019cited by 1position: middledoi
NXY-059, a Failed Stroke Neuroprotectant, Offers No Protection to Stem Cell-Derived Human Neurons
Journal of Stroke and Cerebrovascular Diseases 2018cited by 30position: firstdoi
Derivation of phenotypically diverse neural culture from hESC by combining adherent and dissociation methods
Journal of Neuroscience Methods 2018cited by 3position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Terence J. O’Brien · Monash Health6 papers (2023–2025)Amelia J. Hicks · Monash Alfred Psychiatry Research centre5 papers (2023–2024)Adelle M. Gadowski · Monash University5 papers (2023–2024)Jennie Ponsford · Epworth Hospital5 papers (2023–2024)Natasha A. Lannin · The Alfred Hospital5 papers (2023–2024)Matthew K. Bagg · UNSW Sydney5 papers (2023–2024)Belinda J. Gabbe · Monash Health5 papers (2023–2024)Peter Cameron · Monash Health5 papers (2023–2024)Melinda Fitzgerald · Curtin University5 papers (2023–2024) · 5 papers (2023–2024)David W. Howells · The University of Melbourne4 papers (2018–2019)Jemma Keeves · Australian Regenerative Medicine Institute4 papers (2023–2024) · 4 papers (2023–2024)D. James Cooper · Eli Lilly (Canada)4 papers (2023–2024) · 4 papers (2023–2024) · 3 papers (2023–2024)Mirella Dottori · University of Wollongong3 papers (2018–2019) · 2 papers (2018–2019) · 2 papers (2024–2024)Ye Liu · Sun Yat-sen University2 papers (2018–2019)